Barinthus Biotherapeutics (BRNS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.03
0.06 (6.19%)
At close: Jan 15, 2025, 12:05 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -1.93 | 16.39 | -8.12 | -0.04 | n/a |
PS Ratio | 176.62 | 1.96 | 1.54K | 0.14 | n/a |
PB Ratio | 0.76 | 0.36 | 1.64 | -0.02 | n/a |
P/FCF Ratio | -2.51 | -4.26 | -12.25 | -0.06 | n/a |
P/OCF Ratio | -2.78 | -6.07 | -12.68 | -0.06 | n/a |
OCF/S Ratio | -63.5 | -0.32 | -121.58 | -2.29 | -2.73 |
Debt / Equity Ratio | 0.07 | 0.04 | 0.03 | -1.24 | -0.08 |
Quick Ratio | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
Current Ratio | 12.45 | 17.40 | 20.32 | 6.27 | 2.83 |
Asset Turnover | 0.00 | 0.17 | 0.00 | 0.10 | 0.36 |
Interest Coverage | -3.00K | -212.68 | -16.95 | -5.57 | -193.33 |
Return on Equity (ROE) | -0.39 | 0.02 | -0.2 | 0.47 | 0.93 |
Return on Assets (ROA) | -0.34 | 0.02 | -0.18 | -0.35 | -1.09 |
Return on Capital (ROIC) | -0.42 | -0.02 | -0.17 | -0.47 | -1.94 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Net Profit Margin | -9.15K% | 11.95% | -18.98K% | -367.27% | -302.84% |
Pretax Profit Margin | -9.54K% | 1.90% | -19.08K% | -370.01% | -331.6% |
Operating Profit Margin | -10.46K% | -9.04% | -16.87K% | -415.81% | -374.94% |
FCF Margin | -7.02K% | -46.01% | -12.59K% | -234.83% | -274.8% |
EBITDA Margin | -8.86K% | 14.33% | -17.86K% | -293.29% | -324.61% |